Observational analysis shows improved liver function and reduced oxidative stress in NASH mice, suggesting Citrus reticulata nanoparticles may mitigate liver damage.
is known for its wide variety of secondary metabolites, including essential oil, alkaloids, flavonoids, and phenolic acids, which are considered the reason for its diverse potential medical uses. Herein, extract was prepared using different formulas of metal oxide nanoparticles as ZnO NPs and MgO NPs with 22.5 ± 1.3 and 18.3 ± 1.5 nm average particle sizes, respectively. The protective effects of extract and its two nano formulas against NASH induced by a high-fat, high-sucrose (HFS) diet in mice were evaluated. The NASH mice showed hepatic steatosis, inflammation, reduced liver function, increased body, liver, and fat weights, elevated hepatic index, and disrupted serum lipid profiles. Additionally, the mice displayed heightened hepatic oxidative stress and increased expression of inflammatory and profibrotic markers, along with altered lipid metabolism, indicated by elevated levels of SIRT-1, FGF-21, and SREBP-1c. Notably, treatment with extract and its metallic nanoparticle formulations alleviated these abnormalities, with the most significant improvement observed in the MgO NP formulation. Finally, extract was subjected to a deep phytochemical screening through Liquid chromatography combined with mass spectrometry (LC-MS/MS) analysis, revealing the presence of a high diversity of polyphenolics that may contribute to the suggested therapeutic effects of the crude extract. A molecular docking study highlighted the binding affinities of all identified flavonoid compounds, especially Quercetin, toward IL-1β, TNF-α, and TGF-β target proteins. This shows good translation for the cumulative anti-inflammatory effect depicted by the crude extract. Thermodynamic stability of Quercetin toward each bound proinflammatory protein was confirmed through 150 ns all-atom molecular dynamics simulations. Overall, current findings suggest that exerts a protective effect against NASH, which could be enhanced by nano formulas.
No takes yet. Share an insight, caveat, or question.
Elhady et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: